Dengue Human Infection Models Supporting Drug Development
Dengue is a arboviral infection that represents a major global health burden. There is an unmet need for effective dengue therapeutics to reduce symptoms, duration of illness and incidence of severe complications. Here, we consider the merits of a dengue human infection model (DHIM) for drug develop...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Journal Article |
| Language: | English |
| Published: |
2018
|
| Online Access: | https://demo7.dspace.org/handle/123456789/160 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Dengue Human Infection Models Supporting Drug Development
- The Effects of Tertiary and Quaternary Infections on the Epidemiology of Dengue
- Liver Involvement Associated with Dengue Infection in Adults in Vietnam
- Effect of repeat human blood feeding on Wolbachia density and dengue virus infection in Aedes aegypti
- Wolbachia Reduces the Transmission Potential of Dengue-Infected Aedes aegypti
- Assessment of Microalbuminuria for Early Diagnosis and Risk Prediction in Dengue Infections
- An In-Depth Analysis of Original Antigenic Sin in Dengue Virus Infection